Vimarsana
Biggest News Aggregation in the World

Page 10 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Pinnacle Wealth Management Advisory Group LLC - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Pinnacle Wealth Management Advisory Group LLC

Pinnacle Wealth Management Advisory Group LLC reduced its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) by 6.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 43,500 shares of the company’s stock after selling 3,237 shares during the period. Pinnacle Wealth Management Advisory […]

BridgeBio Pharma (NASDAQ:BBIO) versus Oncorus (NASDAQ:ONCR) Head-To-Head Analysis - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) versus Oncorus (NASDAQ:ONCR) Head-To-Head Analysis

BridgeBio Pharma (NASDAQ:BBIO – Get Rating) and Oncorus (NASDAQ:ONCR – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability. Risk and Volatility BridgeBio Pharma has a beta of 0.71, indicating […]

Source: wkrb13.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Sees Large Drop in Short Interest - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Sees Large Drop in Short Interest

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 15,160,000 shares, a drop of 13.5% from the March 15th total of 17,520,000 shares. Currently, 13.4% of the company’s stock are short sold. Based on an average […]

BridgeBio Pharma (NASDAQ:BBIO) Trading Down 5.3% - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Trading Down 5.3%

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) were down 5.3% on Friday . The stock traded as low as $15.52 and last traded at $15.59. Approximately 965,829 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 2,905,068 shares. The stock had previously closed at $16.47. Analyst […]

Source: wkrb13.com
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $15.15 - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $15.15

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $15.15, but opened at $16.19. BridgeBio Pharma shares last traded at $15.78, with a volume of 355,107 shares trading hands. Analysts Set New Price Targets A number of equities research analysts have […]